AW
Aaron Waxman
Brigham and Women's Hospital, Harvard University
Research areas: Medicine · Pulmonary and Respiratory Medicine · Pulmonary Hypertension Research and Treatments · Vascular Anomalies and Treatments · Cardiovascular and exercise physiology
0000-0001-7797-0361
Employment
-
Brigham and Women's Hospital Executive Director, Center for Pulmonary Heart Disease2009 - Present
-
Harvard University Professor of Medicine
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (30)
- Invasive cardiopulmonary exercise testing: Physiologic assessment of unexplained dyspnea and exercise intolerance Save
- Impact of patient positioning on hemodynamic assessment: A comparison of supine and upright right heart catheterization Save
- Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structures Save
- Pericardial effusion in sotatercept phase 3 trials: insights from STELLAR and ZENITH Save
- A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA Save
- Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR) Save
- Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension Save
- Dyspnea and Right-Sided Heart Failure in a Patient With a History of Pneumonectomy Save
- Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death Save
- National Consortium on Pulmonary Vascular Disease Fellowship Training Summary Save
- Impact of Patient Positioning on Hemodynamic Assessment: A Comparison of Supine and Upright Right Heart Catheterization in Pulmonary Hypertension and HFpEF Save
- Chest Computed Tomography to Improve Phenotyping in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease Save
- Pulmonary Arterial Hypertension and TGF-β Superfamily Signaling: Focus on Sotatercept Save
- Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension Save
- The casting of invasive cardiopulmonary exercise testing: towards a common goal Save
- SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension Save
- Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension Save
- A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial Save
- Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial Save
- Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2 Save